Carrier Screening Market worth $8.13 billion by 2030, growing at a CAGR of 14.93% - Exclusive Report by 360iResearch

The "Carrier Screening Market by Type (Expanded Carrier Screening, Targeted Disease Carrier Screening), Medical Condition (Hematological Conditions, Neurological Conditions, Pulmonary Conditions), Technology, End-User - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.

The Global Carrier Screening Market to grow from USD 3.07 billion in 2023 to USD 8.13 billion by 2030, at a CAGR of 14.93%.

Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/carrier-screening?utm_source=openpr&utm_medium=referral&utm_campaign=sample

Carrier screening is genetic testing conducted on individuals to determine whether they carry a gene for certain genetic disorders. As carriers, these individuals typically do not exhibit symptoms of the disorder; however, they can pass the gene on to their offspring, who may be at risk of inheriting the disease. Carrier screening is particularly recommended for individuals with a family history of genetic disorders or for those within certain ethnic groups that have a higher prevalence of specific genetic conditions. The increasing prevalence of inherited diseases, growing awareness among potential parents, and supportive government policies aimed at reducing the burden of genetic disorders increase the adoption of carrier screening. However, concerns associated with genetic data, the complexity of genetic counseling, and occasional false positives/negatives could lead to cumbersome follow-up testing and impending market growth. Nevertheless, the integration of next-generation sequencing (NGS) technologies, which allow for comprehensive screening of a large number of genetic conditions at once, the potential for growth in direct-to-consumer genetic testing services, and the expansion of carrier screening programs at the population level in various countries are expected to create potential opportunities for the market growth.

The Americas have a mature market for carrier screening, owing to heightened awareness, technological advancements, and the presence of key market players. In the United States, there is a considerable consumer need for carrier screening due to the diverse genetic makeup of the population and increasing healthcare expenditure. The Affordable Care Act has also impacted the market positively by enabling a broader population to access such screenings. Physician recommendations and the availability of direct-to-consumer genetic testing services influence customer purchasing behavior in these regions. Key patents include advances in sequencing technologies and bioinformatics algorithms for detecting genetic variants. The European market is characterized by consumer needs and purchasing behavior across EU countries, shaped by cultural perspectives, healthcare policies, and genetic counseling practices. Nations with more robust healthcare infrastructure and higher per capita income, such as the Scandinavian countries, exhibit higher adoption rates of carrier screening. Initiatives, including the Horizon Europe program, support research and innovation in the field while GDPR legislates genetic data management. Recent investments are seen in public-private partnerships aimed at enhancing genetic testing technologies. The Middle East is experiencing an increase in demand for carrier screening due to high consanguinity rates, leading to a greater prevalence of genetic disorders. Countries in the Middle East are investing in population-scale genetic projects to improve public health. In Asia-Pacific, carrier screening markets are experiencing rapid growth due to increased investment in healthcare infrastructure. Government initiatives such as the "Healthy China 2030" blueprint and the "Genome Japan" project reflect the country's commitment to advancing genomic medicine. Countries in Asia-Pacific present a vast opportunity, with a burgeoning middle class and increasing healthcare awareness. Patents in the Asia Pacific region are focusing on new genetic technologies and cost-effective testing methods to cater to the growing market. Overall, the region presents a significant potential for growth and innovation in carrier screening.

Market Segmentation & Coverage:

This research report categorizes the Carrier Screening Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Expanded Carrier Screening and Targeted Disease Carrier Screening. The Expanded Carrier Screening is further studied across Customized Panel Testing and Predesigned Panel Testing. The Targeted Disease Carrier Screening is projected to witness significant market share during forecast period.

Based on Medical Condition, market is studied across Hematological Conditions, Neurological Conditions, and Pulmonary Conditions. The Neurological Conditions is projected to witness significant market share during forecast period.

Based on Technology, market is studied across DNA Sequencing, Microarrays, and Polymerase Chain Reaction. The Microarrays is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Hospitals, Physician Offices & Clinics, and Reference Laboratories. The Reference Laboratories is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.41% in 2023, followed by Europe, Middle East & Africa.

Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/carrier-screening?utm_source=openpr&utm_medium=referral&utm_campaign=inquire

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Carrier Screening Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in the Carrier Screening Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

Key Company Profiles:

The report delves into recent significant developments in the Carrier Screening Market, highlighting leading vendors and their innovative profiles. These include 23Andme Inc., Abbott Laboratories, Ambry Genetics Corporation by Konica Minolta, Inc., Asper Biogene, Autogenomics Inc. by Prescient Medicine Holdings Inc., BGI Genomics Co., Ltd., Biora Therapeutics, Inc., CENTOGENE N.V., Danaher Corporation, Eurofins Scientific, F. Hoffmann-La Roche Ltd., Fulgent Genetics, Inc., Gene by Gene, Ltd. by myDNA Inc., GeneDx Holdings Corp., Illumina Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Luminex Corporation by DiaSorin Company, MedGenome Labs Ltd., Myriad Genetics, Inc., Natera, Inc., OPKO Health, Inc., Otogenetics Corporation, Quest Diagnostics Inc., Thermo Fisher Scientific Inc., and TRUE HEALTH LABS.

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Carrier Screening Market, by Type
7. Carrier Screening Market, by Medical Condition
8. Carrier Screening Market, by Technology
9. Carrier Screening Market, by End-User
10. Americas Carrier Screening Market
11. Asia-Pacific Carrier Screening Market
12. Europe, Middle East & Africa Carrier Screening Market
13. Competitive Landscape
14. Competitive Portfolio

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Carrier Screening Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Carrier Screening Market?
3. What is the competitive strategic window for opportunities in the Carrier Screening Market?
4. What are the technology trends and regulatory frameworks in the Carrier Screening Market?
5. What is the market share of the leading vendors in the Carrier Screening Market?
6. What modes and strategic moves are considered suitable for entering the Carrier Screening Market?

Read More @ https://www.360iresearch.com/library/intelligence/carrier-screening?utm_source=openpr&utm_medium=referral&utm_campaign=analyst

Contact 360iResearch

Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550

About 360iResearch

360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

This release was published on openPR.